openPR Logo
Press release

Drug-induced Nephrotoxicity Treatment Market Value Projected to Expand during 2022-2032 | Aushon BioSystem Inc., Epistem Ltd G.E., Healthcare Inc.

01-24-2022 02:38 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

The market report by Fact.MR envelopes an all-in information of the global Drug-induced Nephrotoxicity Treatment market and the nature of the market growth over the foreseeable period.

The report provides a comprehensive elaboration of the positives and negatives of the global Drug-induced Nephrotoxicity Treatment market with DROT and Porter’s Five Forces analysis.

To Get In-depth Information View Full Report - https://www.factmr.com/report/1525/druginduced-nephrotoxicity-treatment-market

The Market Research Survey by “Fact.MR, A Market Research and Competitive Intelligence Provider” highlights the key reasons behind increasing demand of Drug-induced Nephrotoxicity Treatment.

The Market Survey examines the Global Drug-induced Nephrotoxicity Treatment Sales for the forecast period 2022- 2031. The report examines the Drug-induced Nephrotoxicity Treatment market key trends, growth opportunities and Drug-induced Nephrotoxicity Treatment market size.

To Get In-depth Insights Request for Sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=1525

Drug-induced Nephrotoxicity Treatment Market: Segmentation

Tentatively, the global drug-induced nephrotoxicity treatment market can be segmented on the basis of biomarker and end users, and geography.

Based on biomarkers, the global drug-induced nephrotoxicity treatment market is segmented as:

Immunoglobulin G
Albumin
Microglobulins
Cystatin C Retinol binding protein
Cytokines
Interferons
Interleukins
N-Acetyl-D-Glucosaminidase
Clusterin
Osteopontin
Kidney Injury Molecule-1 (KIM-1)
Neutrophil gelatinase-associated lipocalin (NGAL)

Based on end users, the global drug-induced nephrotoxicity treatment market is segmented as:

Pharmaceutical and Biotechnology Companies
Academic Institutes
Research Organizations
Others

Key questions answered in Drug-induced Nephrotoxicity Treatment Market Survey Report:

1) What is the current scenario and key trends in Drug-induced Nephrotoxicity Treatment Market?
2) What are the key strategies companies are adopting to increase their consumer base?
3) What are the key categories within the Drug-induced Nephrotoxicity Treatment segments and their future potential?
4) What is the Drug-induced Nephrotoxicity Treatment Market size and what are the opportunities for the key players?
5) What are the major Drug-induced Nephrotoxicity Treatment Market drivers and their expected impact during the short, medium, and long terms?

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=1525

Drug-induced Nephrotoxicity Treatment Market: Key Players

Examples of some of the key players operating in the global drug-induced nephrotoxicity treatment market are

Roche Diagnostic Limited
Siemens Healthcare
Abbott Laboratories Inc.
Thermo Fisher Scientific Inc.
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
Aushon BioSystem Inc.
Epistem Ltd
G.E. Healthcare Inc.
Affymetrix Inc.

Companies are conducting research for the development of new drug-induced nephrotoxicity treatment biomarkers which expected to provide the high growth opportunity for drug-induced nephrotoxicity treatment market.

Essential Takeaways from the Drug-induced Nephrotoxicity Treatment Market Report

i) Comparison of prominent players operating in the Drug-induced Nephrotoxicity Treatment market.
ii) Recent developments and key strategies adopted by market players.
iii) Study of the micro and macro-economic growth indicators.
iv) Impact of the various factors on the value chain of the Drug-induced Nephrotoxicity Treatment market.
v) Growth opportunities for emerging market players in various regional markets.
vi) Current trends influencing the scenario of the Drug-induced Nephrotoxicity Treatment market.

Get Access To TOC Covering 200+ Topics - https://www.factmr.com/connectus/sample?flag=T&rep_id=1525

The Report Covers Exhaustive Analysis On:

1) Drug-induced Nephrotoxicity Treatment Market Drivers, Segments and Restraints.
2) Drug-induced Nephrotoxicity Treatment Market Survey and Dynamics
3) Drug-induced Nephrotoxicity Treatment Market Size & Demand
4) Drug-induced Nephrotoxicity Treatment Key Trends/Issues/Challenges
5) Drug-induced Nephrotoxicity Treatment Sales, Competition & Companies involved

Read More Trending and Similar Reports from Fact.MR – https://www.einpresswire.com/article/557146132/asia-to-account-for-40-of-the-market-share-of-nano-lubricants-over-the-forecast-period

Contact
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website - https://www.factmr.com/
Research Insight - https://www.factmr.com/report/1525/druginduced-nephrotoxicity-treatment-market

About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug-induced Nephrotoxicity Treatment Market Value Projected to Expand during 2022-2032 | Aushon BioSystem Inc., Epistem Ltd G.E., Healthcare Inc. here

News-ID: 2536582 • Views:

More Releases from Fact.MR

Piston Ring Compressors Market Set to Reach USD 1.02 Billion by 2035: India Leads Growth with 7.8% CAGR, Innovation Driving Next-Gen Engine Assembly Efficiency
10-08-2025 | Health & Medicine
Fact.MR
Piston Ring Compressors Market Set to Reach USD 1.02 Billion by 2035: India Lead …
According to a recent study by Fact.MR, the global piston ring compressors market is poised to grow significantly from USD 615 million in 2025 to USD 1,021 million by 2035, expanding at a CAGR of 5.2%. This steady upward trend is being driven by the increasing demand for engine efficiency, precision assembly tools, and the global expansion of automotive and industrial machinery sectors. The manual piston ring compressors segment continues to
Non-Contact ECG Sensors Market to Surpass USD 4.1 Billion by 2035, Driven by AI-Powered Remote Cardiac Monitoring and Telehealth Expansion
10-08-2025 | Health & Medicine
Fact.MR
Non-Contact ECG Sensors Market to Surpass USD 4.1 Billion by 2035, Driven by AI- …
Fact.MR's latest study reveals a 12.2% CAGR for the Non-Contact ECG Sensors Market (2025-2035), signaling an era of intelligent, patient-friendly cardiovascular monitoring solutions. The global non-contact ECG sensors market is set to witness robust growth, rising from USD 1.3 billion in 2025 to USD 4.1 billion by 2035, according to a new report by Fact.MR. The market's trajectory reflects the growing preference for non-invasive, AI-integrated cardiac monitoring solutions, coupled with the
Bioelectric Catheters Market Poised to Surpass USD 9.7 Billion by 2035 Amid Growing Demand for AI-Driven and Minimally Invasive Cardiac & Neurological Interventions
10-08-2025 | Health & Medicine
Fact.MR
Bioelectric Catheters Market Poised to Surpass USD 9.7 Billion by 2035 Amid Grow …
The global Bioelectric Catheters Market is set to expand at an impressive CAGR of 10.4% between 2025 and 2035, rising from an estimated USD 3.6 billion in 2025 to reach USD 9.7 billion by 2035, according to the latest insights from Fact.MR. The market's rapid acceleration is attributed to the rising prevalence of cardiovascular and neurological diseases, increasing adoption of minimally invasive surgeries, and the integration of AI and IoT-enabled
AI-Based Spirometers Market Set to Surge to USD 536.9 Million by 2035 - Driven by AI Integration, Telehealth Expansion, and Preventive Respiratory Care
10-08-2025 | Health & Medicine
Fact.MR
AI-Based Spirometers Market Set to Surge to USD 536.9 Million by 2035 - Driven b …
The global AI-based spirometers market is on a strong growth trajectory, forecasted to climb from USD 89.7 million in 2025 to an impressive USD 536.9 million by 2035, according to a new study by Fact.MR. This growth, at a CAGR of 19.6%, underscores the transformative role of artificial intelligence (AI) in redefining respiratory diagnostics and patient monitoring worldwide. As healthcare systems globally shift toward preventive and precision medicine, AI-based spirometry devices

All 5 Releases


More Releases for Nephrotoxicity

Platinum-based Chemotherapy and Nephrotoxicity Market to Reach USD 2.8 Billion b …
Platinum-based chemotherapy-primarily involving cisplatin, carboplatin, and oxaliplatin-remains a cornerstone in the treatment of various solid tumors, including lung, ovarian, testicular, and bladder cancers. These agents are highly effective due to their DNA-damaging mechanisms, but they carry significant risks, notably nephrotoxicity (kidney damage). Nephrotoxicity can manifest as acute kidney injury (AKI) or chronic kidney disease (CKD), often necessitating dose adjustments or discontinuation of therapy, impacting overall treatment outcomes. Download Full PDF Sample
Platin Based Chemotherapies And Nephrotoxicity Therapeutics Market Size in the 7 …
DelveInsight's "Platinum-based Chemotherapy and Nephrotoxicity Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Platinum-based Chemotherapy and Nephrotoxicity, historical and forecasted epidemiology as well as the Platinum-based Chemotherapy and Nephrotoxicity trends in the United States, EU4 (Germany, France, Italy, and Spain) and the UK, and Japan. Discover Key Insights into the Platin based chemotherapies and nephrotoxicity Market with DelveInsight's In-Depth Report @ Platin based chemotherapies
Booming Demand in the Drug-induced Nephrotoxicity Treatment Market Will Drive an …
Drug-induced Nephrotoxicity Treatment Market research report provides all specific industry data from 2023 to 2030. By providing its clients with accurate data, it also gives a market outlook and aids in the making of crucial decisions. The market is described in general terms, along with its description, uses, advancements, and production technology. This research report on Drug-induced Nephrotoxicity Treatment keeps tabs on all existing market breakthroughs and changes. It provides
Drug-induced Nephrotoxicity Treatment Market Trends and Forecast Report 2022 | B …
The QY Research released a latest market research report on the global and United States Drug-induced Nephrotoxicity Treatment market, which is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Drug-induced Nephrotoxicity Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by
Drug-induced Nephrotoxicity Treatment Market Trends, Regulations And Competitive …
Drug-induced nephrotoxicity or drug-induced kidney disease (DIKD) is primarily recognized as a significant contributor to kidney disease including acute kidney injury (AKI) and chronic kidney disease (CKD). Drug-induced nephrotoxicity is often go unrecognized, particularly in the setting of short drug exposures, which leads challenges in assessing the incidence, severity and long-term consequences of drug-induced kidney disease. The mechanisms for drug-induced nephrotoxicity include changes in glomerular hemodynamics, tubular cell toxicity, inflammation,
Drug-induced Nephrotoxicity Treatment Market: Future Forecast Indicates Impressi …
Drug-induced nephrotoxicity or drug-induced kidney disease (DIKD) is primarily recognized as a significant contributor to kidney disease including acute kidney injury (AKI) and chronic kidney disease (CKD). Drug-induced nephrotoxicity is often go unrecognized, particularly in the setting of short drug exposures, which leads challenges in assessing the incidence, severity and long-term consequences of drug-induced kidney disease. The mechanisms for drug-induced nephrotoxicity include changes in glomerular hemodynamics, tubular cell toxicity, inflammation,